Waukegan Illinois Hospital Company LLC
Waukegan Illinois Hospital Company LLC was paid $2.30M by Medicaid between Jan 2018 and Jul 2024, across 85 billing codes. Its largest line is 97110, Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion — 76% of everything it billed.
WAUKEGAN, IL 60085
Next to other General Acute Care Hospital providers in Illinois
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 24,628 | $787K | |
| 2019 | 32,216 | $1.16M | |
| 2020 | 9,125 | $339K | |
| 2021 | 605 | $3K | |
| 2022 | 1,269 | $8K | |
| 2023 | 1,152 | $9K | |
| 2024incomplete | 31 | $59.79 |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 76% | 15,119 | 1,928 | $1.76M |
| 87799 | 4.7% | 1,180 | 909 | $109K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 4.1% | 1,614 | 1,492 | $94K |
| 97162 | 2.2% | 424 | 263 | $51K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 1,866 | 1,474 | $21K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 1,864 | 1,473 | $20K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 1,617 | 276 | $20K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 1,023 | 726 | $18K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | <1% | 556 | 306 | $18K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | <1% | 520 | 334 | $16K |
| 80053 | Comprehensive metabolic panel | <1% | 5,288 | 4,205 | $16K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 766 | 557 | $14K |
73 more codes
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 795 | $14K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 2,515 | $14K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 1,353 | $13K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 147 | $12K |
| 87481 | <1% | 1,028 | $9K | |
| 87512 | <1% | 1,224 | $8K | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 1,411 | $8K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 910 | $8K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 3,745 | $6K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 344 | $5K |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 510 | $4K |
| 85027 | <1% | 2,609 | $4K | |
| 73030 | <1% | 259 | $3K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 2,463 | $3K |
| 80061 | Lipid panel | <1% | 2,556 | $3K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 814 | $2K |
| 72110 | <1% | 114 | $2K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 1,034 | $2K |
| 36415 | Collection of venous blood by venipuncture | <1% | 2,550 | $2K |
| 84439 | <1% | 1,083 | $2K | |
| 72100 | <1% | 173 | $2K | |
| 73564 | <1% | 131 | $2K | |
| 86803 | <1% | 431 | $2K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 494 | $1K |
| 87340 | <1% | 414 | $1K | |
| 88142 | <1% | 929 | $1K | |
| 73562 | <1% | 100 | $1K | |
| 82607 | <1% | 307 | $965.53 | |
| 73630 | <1% | 93 | $950.61 | |
| 81220 | CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants | <1% | 90 | $784.56 |
| 73130 | <1% | 85 | $763.78 | |
| 81001 | <1% | 1,214 | $694.63 | |
| 82570 | <1% | 644 | $624.76 | |
| 86592 | <1% | 719 | $599.43 | |
| 86038 | <1% | 55 | $584.55 | |
| 86696 | <1% | 47 | $567.07 | |
| 86787 | <1% | 167 | $506.18 | |
| 85610 | <1% | 402 | $476.95 | |
| 84702 | <1% | 148 | $405.63 | |
| 86762 | <1% | 230 | $371.36 | |
| 87081 | <1% | 183 | $292.94 | |
| 82043 | <1% | 369 | $284.17 | |
| 84152 | <1% | 76 | $260.26 | |
| 83021 | <1% | 85 | $252.78 | |
| 86850 | <1% | 185 | $245.16 | |
| 81003 | <1% | 431 | $220.84 | |
| 86778 | <1% | 47 | $219.07 | |
| 86695 | <1% | 37 | $212.82 | |
| 86901 | <1% | 180 | $181.04 | |
| 86777 | <1% | 43 | $148.23 | |
| 86900 | <1% | 179 | $145.45 | |
| 87428 | <1% | 18 | $127.88 | |
| 87077 | <1% | 51 | $126.56 | |
| 82950 | <1% | 86 | $118.06 | |
| 83735 | <1% | 60 | $112.26 | |
| 82746 | <1% | 69 | $108.71 | |
| 81025 | <1% | 45 | $105.27 | |
| 80074 | <1% | 13 | $98.27 | |
| 84144 | <1% | 34 | $97.89 | |
| 82728 | <1% | 71 | $94.21 | |
| 88141 | <1% | 101 | $91.86 | |
| 83540 | <1% | 87 | $83.06 | |
| 87186 | <1% | 15 | $74.93 | |
| 84156 | <1% | 103 | $51.71 | |
| 85651 | <1% | 59 | $50.28 | |
| 84550 | <1% | 36 | $50.11 | |
| 82947 | <1% | 50 | $35.16 | |
| 86140 | <1% | 42 | $34.85 | |
| 83615 | <1% | 16 | $18.15 | |
| 83550 | <1% | 16 | $17.48 | |
| 85018 | <1% | 29 | $15.44 | |
| 85014 | <1% | 13 | $8.30 | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 0% | 23 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
Who's on the registration
| Provider | Location | Paid |
|---|---|---|
| Jackson Hospital Corporation | Jackson, KY | $34.90M |
| Deming Hospital Corporation | Deming, NM | $34.61M |
| Hospital of Louisa, INC. | Louisa, KY | $27.77M |
| Hospital of Barstow INC | Barstow, CA | $16.88M |
| Paintsville Hospital Company, LLC | Paintsville, KY | $15.46M |
| San Miguel Hospital Corporation | Las Vegas, NM | $13.21M |
| Tooele Hospital Corporation | Tooele, UT | $11.66M |
| Forrest City Arkansas Hospital Company LLC | Forrest City, AR | $7.42M |
| MMC of Nevada LLC | Mesquite, NV | $2.60M |
| Fort Payne Hospital Corporation | Fort Payne, AL | $2.60M |
| Williamston Hospital Corporation | Williamston, NC | $2.31M |
| Southwest Kidney Institute Vascular Center LLC | Tempe, AZ | $850K |
| Evanston Hospital Corporation | Evanston, WY | $378K |
| Marion Hospital Corporation | Marion, IL | $220K |
| Anna Hospital Corporation | Anna, IL | $217K |
| National Healthcare of MT Vernon INC | Mount Vernon, IL | $158K |
| Red Bud Illinois Hospital Company LLC | Red Bud, IL | $36K |
| Tooele Hospital Corporation | Tooele, UT | $5K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.